Commerce Bancshares
CBSH
$55.89
-0.25%
Commerce Bancshares Inc. is the bank holding company for Commerce Bank, a regional financial institution operating across three reportable segments — Commercial (lending, leasing, deposits, payments and cash management for businesses and municipalities), Retail Banking (consumer deposits, lending, mortgage banking and card services) and Wealth (trust, estate planning, brokerage and investment management). Unlike many regional peers that chase national scale, CBSH is a conservatively run, fee-rich franchise anchored in the Midwest with a long-standing reputation for credit discipline and a meaningful wealth-management and payments mix that differentiates it from plain-vanilla spread lenders. The current investor debate centers on the durability of net interest income as deposit costs and loan yields reprice, the trajectory of non-interest income from trust and card fees, and whether the bank's premium book valuation can be sustained against a regional-bank backdrop still shadowed by credit-quality and regulatory scrutiny. Recent quarterly results showing revenue growth and margin expansion have reinforced the quality-growth narrative, though the stock's muted one-year relative performance versus the S&P 500 keeps valuation and rate sensitivity at the center of the conversation.…
CBSH
Commerce Bancshares
$55.89
Related headlines
Investment Opinion: Should I buy CBSH Today?
Rating: Hold, with a constructive bias. The core thesis is that CBSH is a high-quality, fee-rich Midwest franchise earning a 14.94% ROE and trading at 12.83x trailing earnings and 1.92x book — near the low end of its own multi-year band — but with only 7 analysts covering it and a consensus that leans Equal Weight/Neutral, there is no clear catalyst to force a re-rating in the near term. Morgan Stanley's Overweight upgrade in September 2026 and the $4.98 consensus EPS (implying roughly $64 of fair value, about +16% above the $55.04 price) anchor a mildly positive skew, but the neutral ratings from Stephens, Piper Sandler, Wells Fargo and KBW cap conviction.
The supporting evidence is solid rather than spectacular. Q3 2026 revenue of $588.2 million grew 8.22% year-over-year, gross margin expanded roughly 345 basis points to 82.34% from 78.89%, and net margin improved to 26.35% from 26.04%, while net income rose to $155.0 million from $141.5 million. Trailing free cash flow of $1.26 billion ($1.69 per share) comfortably covers the $39.6 million quarterly dividend and $110.7 million of Q3 buybacks, and the 2.07% yield carries a conservative 26.5% payout ratio. Against regional-bank norms the 1.92x P/B is a premium to the typical 1.0x-1.5x range, but the 12.83x PE sits near the low end of its own 11.3x-15.3x three-year range and well below the 14.5x-17.5x seen in 2021-2022, so the stock is fairly valued to modestly cheap on earnings even if rich on book.
The biggest risks that could invalidate the thesis are a rollover in net interest margin as deposit costs reprice (the Q2 2026 revenue dip to $498.9 million from $584.0 million in Q1 shows how quickly interest-income timing can distort results), a credit deterioration in the commercial loan book that would compress the premium P/B multiple toward peer levels, and thin sponsorship that makes a single downgrade from the small analyst cohort disproportionately damaging. This Hold would upgrade to Buy if the stock pulls back toward the $50.32 52-week low (roughly 1.75x book) or if Q4 results confirm gross margin holding above 80% with continued fee growth; it would downgrade to Sell if net interest margin compresses for two consecutive quarters or if the stock breaks decisively below the $53.91-$54.29 October support cluster. Net verdict: fairly valued relative to history, at a modest premium to peers that is justified by superior returns on capital — a quality franchise worth owning, but not at a price that demands urgency.
Sign up to view all
CBSH 12-Month Price Forecast
CBSH screens as a fairly valued quality franchise rather than a compelling opportunity: the 12.83x trailing PE is near the low end of its own history and the 14.94% ROE justifies a premium to peers, but the 1.92x P/B already prices in much of that quality and the stock has lagged the S&P 500 by 1.85 points over the past year. The near-term setup is constructive — gross margin up roughly 345 basis points, revenue up 8.22%, and a 7.09-point one-month relative outperformance versus SPY — but the thin, neutral-leaning analyst cohort and the failure to clear the $60.33 double-top cap the upside. The 12-month skew is modestly positive, with the $64 implied fair value offering roughly 16% upside against a bear case that could take the stock to the mid-$40s, a risk/reward of roughly 2:1 that supports a Hold rather than an aggressive Buy. I would upgrade to bullish if Q4 results confirm net interest margin expansion and gross margin holds above 80%, or if the stock breaks decisively above $60.33; I would downgrade to bearish if margin compresses for two consecutive quarters or the stock breaks below the $53.91-$54.29 support cluster.
Wall Street consensus
Coverage is thin but real: 7 analysts publish estimates, with a consensus EPS of $4.98 (range $4.80-$5.21) and average revenue of $2.14 billion (range $2.10-$2.21 billion). The institutional ratings skew neutral — recent actions include Morgan Stanley's Overweight (upgraded from Equal Weight in September 2026), alongside Equal Weight/Neutral/Market Perform stances from Stephens, Piper Sandler, Wells Fargo and KBW — producing a consensus that leans cautiously constructive rather than bullish. With the stock at $55.04 and no explicit price targets in the dataset, implied upside cannot be calculated directly, but the $4.98 consensus EPS against the 12.83x trailing multiple implies a fair value near $64, roughly +16% above the current price.
The signal strength is moderate: the EPS estimate range of $4.80-$5.21 (about 8.4% spread) is relatively tight, indicating reasonable conviction on near-term earnings, while the revenue range of $2.10-$2.21 billion (about 5% spread) is similarly contained. The high end assumes continued net interest margin expansion and fee growth, while the low end prices in deposit-cost pressure or slower loan growth; the absence of recent downgrades and Morgan Stanley's upgrade suggest sentiment is stabilizing. Insufficient explicit price-target data limits precision, but the pattern of neutral-to-overweight ratings from a small analyst cohort is typical of a mid-cap regional bank with limited institutional sponsorship — a setup that can produce outsized moves when fundamentals surprise in either direction.
Drowning in data?
Find the real signal!
Bulls vs Bears: CBSH Investment Factors
The bull case currently holds the stronger evidence: gross margin expanded roughly 345 basis points year-over-year, revenue grew 8.22%, ROE stands at 14.94%, and the stock trades near the low end of its historical PE and P/B bands while outperforming the market by 7.09 points over the past month. The bear case is real but largely valuation- and sentiment-based — thin analyst coverage skewed neutral, a 1.92x P/B premium to regional-bank norms, and a one-year relative strength of -1.85 that shows the quality story has not translated into sustained outperformance. The single most important tension is whether net interest margin expansion can persist as deposit costs and loan yields reprice; if margins hold, the low-end multiple re-rates toward the $64 implied by consensus EPS, but if they roll over, the premium book value compresses toward peer levels. Secondary to that is the trajectory of trust and card fee income, which determines whether CBSH remains a fee-rich quality franchise or drifts back toward a plain-vanilla spread lender.
Bullish
- Margin expansion signals pricing power: Q3 2026 gross margin expanded to 82.34% from 78.89% a year earlier, roughly 345 basis points of improvement, while net margin rose to 26.35% from 26.04%. That combination points to favorable deposit repricing and disciplined expense control rather than a one-off gain, which is the core of the quality-compounder case.
- Steady revenue growth with fee cushion: Q3 2026 revenue of $588.2 million grew 8.22% year-over-year versus $543.5 million, and interest income rose to $402.7 million from $396.0 million in Q2. Fee-based lines such as commission income ($2.45 million) and managed account services ($1.74 million) provide a non-spread cushion that plain-vanilla regional lenders lack.
- Valuation near low end of history: At 12.83x trailing PE and 1.92x price-to-book, CBSH sits near the low end of its multi-year band — P/B ranged 2.11x-3.27x in 2022 and 1.67x-2.27x across 2024-2025, and PE ran 14.5x-17.5x in 2021-2022. The market is pricing modest expectations despite a 14.94% ROE, leaving room for re-rating if margins hold.
- Defensive relative strength in selloffs: CBSH beat SPY by 7.09 percentage points over the past month (+2.10% vs. -4.99%) and by 6.61 points over six months (+6.07% vs. -0.54%). That pattern of outperforming during broad market weakness is characteristic of a low-beta, conservatively run franchise that acts as a relative safe haven.
Bearish
- Thin coverage skews neutral: Only 7 analysts publish estimates, and the ratings mix is Equal Weight/Neutral/Market Perform from Stephens, Piper Sandler, Wells Fargo and KBW, with Morgan Stanley's Overweight the notable exception. Limited institutional sponsorship means the stock lacks a broad bullish catalyst base and can swing sharply on single-analyst actions.
- Rate sensitivity caps earnings leverage: Interest coverage of roughly 2.1x and an equity multiplier near 8.3x underscore a thin-margin, rate-sensitive model. The Q2 2026 revenue dip to $498.9 million from $584.0 million in Q1 shows how quickly interest-income timing and deposit costs can distort quarterly results.
- Relative performance lags the index: The one-year price change of +7.74% trails the S&P 500's +9.59% (relative strength -1.85), and the three-month change of -6.84% badly lags SPY's -4.91% (relative strength -1.93). The outperformance has been uneven, and the stock has failed twice to clear the $60.33 double-top.
- Premium book value needs justification: A 1.92x price-to-book sits above the typical 1.0x-1.5x range for regional banks. That premium rests on the 14.94% ROE and fee-rich mix persisting; any credit deterioration or margin compression would compress the multiple toward peer norms and hit the stock disproportionately.
CBSH Technical Analysis
CBSH is in a choppy, range-bound consolidation rather than a clean trend, with a 1-year price change of +7.74% that modestly trails the S&P 500's +9.59% (relative strength of -1.85). At $55.04, the stock sits roughly 91% of the way through its 180-day range of about $50.32 (May low) to $60.33 (late-July high), meaning it is holding the upper-middle of its band but has failed twice to establish new highs above $60. That positioning signals resilience rather than overextension — momentum is intact but the stock is not stretched, leaving room for either a breakout or a retest of the mid-$50s.
Short-term momentum is diverging constructively from the medium-term trend: the 1-month change is +2.10% while the 3-month change is -6.84%, a sharp reversal that has arrested the late-summer slide from the $60 area. This divergence looks like mean reversion off the September-October pullback rather than a fresh downtrend, and it is confirmed by relative strength: CBSH beat SPY by +7.09 percentage points over the past month even as SPY fell -4.99%, a defensive rotation signal. The 6-month change of +6.07% versus SPY's -0.54% (+6.61 relative) reinforces that the stock has been a relative safe haven, though the 3-month relative strength of -1.93 shows the outperformance has been uneven.
Key technical levels are clear: support clusters at the $53.91-$54.29 October lows, with the 180-day floor at $50.32 as the line in the sand, while resistance sits at the $60.01-$60.33 July/August double-top. A decisive break above $60.33 would confirm a resumption of the uptrend and likely target new highs, whereas a breakdown below $53.91 would signal the consolidation is resolving lower and put the $50.32 low in play. Volatility is moderate — the 180-day max drawdown of -16.14% and a daily volume of roughly 857k shares suggest institutional-grade liquidity without extreme swings, and with a beta near 1.0 (implied by the stock's tight tracking of broad bank sentiment), position sizing can be treated as market-like rather than high-beta.
Beta
—
—
Max Drawdown
-15.4%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+8.0%
Cumulative gain past year
| Period | CBSH Return | S&P 500 |
|---|---|---|
| 1m | +2.4% | -2.4% |
| 3m | -6.8% | -2.3% |
| 6m | +9.7% | +2.8% |
| 1y | +8.0% | +11.3% |
| ytd | +7.0% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBSH Fundamental Analysis
Revenue is growing at a steady, if unspectacular, clip: Q3 2026 revenue of $588.2 million rose +8.22% year-over-year versus $543.5 million in Q3 2025, and the trailing four-quarter run-rate of roughly $2.21 billion is tracking toward the $2.14 billion consensus estimate. The multi-quarter trend is lumpy but upward — Q1 2026 $584.0M, Q2 $498.9M, Q3 $588.2M — with the Q2 dip reflecting seasonal and interest-income timing rather than deterioration, and interest income climbing to $402.7 million in Q3 from $396.0 million in Q2. Fee-based lines (commission income of $2.45 million and managed account services of $1.74 million in the disclosed segment data) provide a non-spread cushion, and the growth trajectory supports the quality-compounder investment case rather than a cyclical rebound story.
Profitability is robust and improving: Q3 2026 net income was $155.0 million on a 26.35% net margin, up from $141.5 million and a 26.04% margin in Q3 2025, while gross margin expanded to 82.34% from 78.89% a year earlier. Operating margin of 34.20% and EBITDA of $198.4 million (33.73% EBITDA margin) are healthy for a regional bank, and the Q2 2026 print showed even stronger operating leverage at 41.28% operating margin on $159.8 million of net income. The margin trajectory — gross margin up roughly 345 basis points year-over-year — points to favorable deposit repricing and disciplined expense control, a hallmark of CBSH's conservative management style.
Balance-sheet and cash-flow metrics are solid but reflect the leverage inherent in banking: debt-to-equity of 0.79 is moderate, ROE of 14.94% is respectable for the sector, and trailing free cash flow of $1.26 billion (FCF per share of $1.69) comfortably funds the $39.6 million quarterly dividend and $110.7 million of Q3 buybacks. Liquidity is ample with $2.40 billion of cash at period-end, though the equity multiplier of roughly 8.3x and interest coverage of about 2.1x underscore the thin-margin, rate-sensitive nature of the model. The 2.07% dividend yield with a conservative 26.5% payout ratio leaves ample room for continued capital return without external financing dependence.
Quarterly Revenue
$588161000.0B
2026-09
Revenue YoY Growth
+8.2%
YoY Comparison
Gross Margin
82.3%
Latest Quarter
Free Cash Flow
$1.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBSH Overvalued?
Because CBSH is profitable — Q3 2026 net income of $155.0 million and trailing EPS of roughly $4.29 — the PE ratio is the appropriate primary metric, and the trailing PE of 12.83x against a forward PE of 2.49x (based on the $4.98 consensus EPS estimate) implies the market expects earnings to roughly quintuple, a gap that almost certainly reflects a data artifact in the forward multiple rather than genuine growth expectations. The more reliable read is the 12.83x trailing PE paired with a 1.92x price-to-book and 3.40x price-to-sales, which frame CBSH as a moderately valued, earnings-supported bank rather than a growth-priced one.
Against regional-bank norms, the valuation is mixed: a 1.92x P/B sits at a premium to the typical 1.0x-1.5x range for regional banks, justified by CBSH's 14.94% ROE and fee-rich mix, while the 12.83x PE is roughly in line with the sector's low-teens multiple and the 3.40x PS is elevated only because bank revenue is reported net of interest expense. The 12.01x EV/EBITDA and 2.07% dividend yield round out a profile that is neither cheap nor expensive — a fair-value quality franchise trading at a modest premium for superior returns on capital.
Historically, CBSH has traded at a premium: its P/B ranged from 2.11x to 3.27x in 2022 and 1.67x to 2.27x across 2024-2025, so the current 1.92x sits near the lower end of its multi-year band and well below the 2022 peak. Its PE of 12.83x compares favorably to the 14.5x-17.5x readings seen in 2021-2022 and is near the low end of the 11.3x-15.3x range over the past three years, suggesting the market is pricing in modest expectations — a potential value opportunity if margin expansion continues, but also a signal that investors remain cautious on rate and credit risk.
PE
12.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~18x
vs. Industry Avg
12.0x
Industry PE ~12.0x*
EV/EBITDA
12.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the bank's inherent leverage and rate sensitivity. The equity multiplier of roughly 8.3x and interest coverage of about 2.1x mean a modest rise in funding costs or a credit shock transmits quickly to earnings, and the Q2 2026 revenue drop to $498.9 million from $584.0 million in Q1 illustrates how interest-income timing can distort results quarter to quarter. Debt-to-equity of 0.79 is moderate but not trivial, and the 26.35% net margin depends on continued deposit repricing discipline — a reversal would hit the 82.34% gross margin that underpins the quality narrative. Revenue is also concentrated in spread income, with fee lines such as commission income ($2.45 million) and managed account services ($1.74 million) too small to offset a sustained net interest margin squeeze.
Market and competitive risks revolve around the premium valuation and thin sponsorship. At 1.92x price-to-book versus the typical 1.0x-1.5x regional-bank range, CBSH carries multiple-compression risk if ROE slips from 14.94% or if credit-quality concerns resurface across the sector. Coverage is limited to 7 analysts with a neutral-leaning consensus, so a single downgrade from Stephens, Piper Sandler, Wells Fargo or KBW could move the stock disproportionately given roughly 857k shares of daily volume. The beta near 1.0 means the stock tracks broad bank sentiment rather than offering diversification, and the one-year relative strength of -1.85 against the S&P 500 shows the market has not rewarded the quality premium. The recent news flow is dominated by peer consolidation such as KeyCorp's Atlantic-Pacific acquisition, a reminder that larger competitors can build capabilities and cross-sell reach that a Midwest-focused franchise cannot easily match.
In a worst-case scenario, a combination of deposit-cost pressure compressing net interest margin, a credit deterioration in the commercial loan book, and a sector-wide de-rating of regional-bank multiples would hit CBSH on both earnings and valuation. The stock's 180-day max drawdown of -16.14% and the 52-week low of $50.32 provide a realistic downside anchor — from the current $55.04, a retest of that low implies roughly -8.6%, and a full re-rating of the P/B multiple toward the 1.5x peer ceiling would imply a deeper decline toward the mid-$40s, roughly -15% to -20%. A break below the $53.91-$54.29 October support cluster would confirm that the consolidation is resolving lower and put the $50.32 floor in play, with the -16.14% historical drawdown as the guide to how far a genuine risk-off episode could extend.
FAQ
Ranked by severity: first, rate and margin risk — with interest coverage near 2.1x and an equity multiplier around 8.3x, a rise in deposit costs transmits quickly to earnings, and the Q2 2026 revenue drop to $498.9 million from $584.0 million in Q1 shows how abruptly interest-income timing can distort results. Second, valuation/multiple-compression risk — the 1.92x P/B rests on the 14.94% ROE persisting; any credit deterioration in the commercial loan book or sector-wide de-rating (highlighted by peer consolidation such as KeyCorp's Atlantic-Pacific deal) could compress the multiple toward the 1.5x peer ceiling, implying a move toward the mid-$40s. Third, sponsorship and liquidity risk — only 7 analysts cover the stock with a neutral-leaning consensus, and at roughly 857k shares of daily volume a single downgrade from Stephens, Piper Sandler, Wells Fargo or KBW could move the price disproportionately. Fourth, relative-performance and macro risk — beta near 1.0 means the stock tracks broad bank sentiment, and its one-year relative strength of -1.85 versus the S&P 500 shows the quality premium has not been rewarded; the 180-day max drawdown of -16.14% is a realistic guide to a risk-off episode.
The base case (55% probability) targets $55-$62, assuming consensus EPS of $4.98 is met within the tight $4.80-$5.21 range, net interest margin holds roughly flat, gross margin stays in the high-70s to low-80s, and the stock continues consolidating between the $53.91-$54.29 support and the $60.01-$60.33 double-top. The bull case (25% probability) targets $64-$68, driven by net interest margin expansion, gross margin above 80%, fee-income growth, continued buybacks (shares already down to 142.2 million from 145.9 million in Q1), and a re-rating to 13x-14x forward earnings. The bear case (20% probability) targets $45-$50, requiring two consecutive quarters of margin compression, commercial credit deterioration, and a sector-wide de-rating that breaks the October support and puts the $50.32 52-week low — and potentially the mid-$40s — in play. The base case is most likely, and its key assumption is that deposit costs and loan yields reprice roughly in tandem, keeping the 12.83x multiple intact.
The answer depends on the metric: on earnings CBSH looks modestly cheap, on book it looks modestly rich. The 12.83x trailing PE sits near the low end of the 11.3x-15.3x range of the past three years and well below the 14.5x-17.5x seen in 2021-2022, while the 1.92x price-to-book is a premium to the typical 1.0x-1.5x regional-bank norm but below its own 2.11x-3.27x 2022 band and within the 1.67x-2.27x range of 2024-2025. The 3.40x price-to-sales and 12.01x EV/EBITDA are unremarkable for a bank with a fee-rich mix, and the reported 2.49x forward PE is almost certainly a data artifact (it would imply earnings roughly quintupling) and should be disregarded. What the market appears to be pricing is a durable but unspectacular franchise: a 14.94% ROE that justifies some book premium, offset by rate sensitivity (interest coverage near 2.1x, equity multiplier near 8.3x) and limited institutional sponsorship. Net, the stock is fairly valued relative to its own history and at a modest, defensible premium to peers — not a bargain, but not stretched.
From a risk/reward standpoint CBSH is reasonable but not compelling: at $55.04 the stock offers roughly +16% upside to the ~$64 implied by the $4.98 consensus EPS at a 12.83x multiple, against a bear case that could take it to the mid-$40s (-15% to -20%) if margins compress and the 1.92x P/B re-rates toward the 1.5x peer ceiling — a skew of roughly 2:1. The quality underpinnings are real: a 14.94% ROE, gross margin of 82.34% (up ~345 basis points year-over-year), net margin of 26.35%, and $1.26 billion of trailing free cash flow covering both the $39.6 million quarterly dividend and $110.7 million of Q3 buybacks. The biggest downside risk is rate-driven — deposit-cost repricing that squeezes net interest margin — compounded by thin sponsorship from only 7 analysts with a neutral-leaning consensus. It is a good buy for patient, income-tolerant investors seeking lower-volatility financial exposure who can accept a 12-18 month holding period and would be comfortable adding near the $50.32 52-week low; it is less attractive for anyone seeking near-term catalysts or high-beta upside, given the stock has lagged the S&P 500 by 1.85 points over the past year.
CBSH is better suited to a medium-to-long-term hold than to short-term trading. It is a mature, conservatively managed bank (founded franchise, listed since 1973, roughly 4,976 employees) with beta near 1.0, moderate volatility (180-day max drawdown of -16.14%), and a modest 2.07% dividend yield backed by a conservative 26.5% payout ratio — a profile that rewards patience rather than momentum. Earnings visibility is decent but not high: the $4.80-$5.21 consensus EPS range is tight (about 8.4% spread), yet quarterly results are visibly rate-sensitive, as the Q1-to-Q2 2026 revenue swing from $584.0 million to $498.9 million demonstrates. Short-term traders would be trading a range-bound tape between roughly $54 and $60 with thin 857k-share volume and limited news flow, which offers little edge. A concrete suggested minimum holding period is 12-18 months — long enough to capture at least two earnings cycles (starting with the Q4 2026 report expected around late January/early February 2027) and to let either the margin-expansion thesis or the re-rating toward the ~$64 implied fair value play out, while collecting roughly 2% annually in dividends along the way.